Use of porcine vaginal tissue ex-vivo to model environmental effects on vaginal mucosa to toxic shock syndrome toxin-1

Toxicology and Applied Pharmacology

Volumn 274, Issue 2, 2014, Pages 240-248

  Davis, Catherine C ^a   Baccam, Mekhine ^a   Mantz, Mary J ^b   Osborn, Thomas W ^a   Hill, Donna R ^a   Squier, Christopher A ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Endotoxin; Permeability; Surfactant; Temperature; Toxic shock syndrome toxin 1 (TSST 1); Vagina

Indexed keywords

ALPHA HEMOLYSIN; BENZALKONIUM CHLORIDE; DODECYL SULFATE SODIUM; GLYCEROL; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; POLYSORBATE 20; TOXIC SHOCK SYNDROME TOXIN 1; TRITIUM OXIDE;

ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CELL MEMBRANE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; MENSTRUAL TOXIC SHOCK SYNDROME; NONHUMAN; PATHOGENESIS; PERMEABILITY; RISK ASSESSMENT; RISK FACTOR; ROOM TEMPERATURE; T LYMPHOCYTE; TAMPON; TISSUE PERFUSION; TOXIC SHOCK SYNDROME; VAGINA MUCOSA;

EID: 84890877285     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.11.021     Document Type: Article

References (59)

1. Abrahams V.M. Toll-Like receptors in the cycling female reproductive tract and during pregnancy. Curr. Wmns. Hlth. Rev. 2005, 1(1):35-42.
2. Anderson M.J., Lin Y.-C., Gillman A.N., Parks P.J., Schlievert P.M., Peterson M.L. Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation. Front. Cell Infect. Microbiol. 2012, 2(64):1-10.
3. Aroutcheva A., Lind Z., Faro S. Prevotella bivia as a source of lipopolysaccharide in the vagina. Anaerobe 2008, 14(5):256-260.
4. Au W.L., Skinner M., Kanfer I. Comparison of tape stripping with the human skin blanching assay for the bioequivalence assessment of topical clobetasol propionate formulations. J. Pharm. Sci. 2010, 13(1):11-20.
5. Ayehunie S., Cannon C., Lamore S., Kibilus J., Anderson D.J., Pudney J., Klausner M. Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and feminine-care products. Toxicol. In Vitro 2006, 29:689-698.
6. Bergdoll M.S., Crass B.A., Reiser R.F., Robbins R.N., Davis J.P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1981, 1(8228):1017-1021.
7. Brosnahan A.J., Mantz M.J., Squier C.A., Peterson M.L., Schlievert P.M. Cytolysins augment superantigen penetration of stratified mucosa. J. Immunol. 2009, 182(4):2364-2373. 10.4049/jimmunol.0803283.
8. Brosnahan A.J., Schlievert P.M. Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome. FEBS J. 2011, 278(23):4649-4667. 10.1111/j.1742-4658.2011.08151.x.
9. Boverhof D.R., Wiescinski C.M., Botham P., Lees D., Debruyne E., Repetto-Larsay M., Ladics G., et al. Interlaboratory validation of 1% pluronic l92 surfactant as a suitable, aqueous vehicle for testing pesticide formulations using the murine local lymph node assay. Toxicol. Sci 2008, 105(1):79-85. (Sep). 10.1093/toxsci/kfn117.
10. Costin G.G., Raabe H.A., Priston R., Evans E., Curren R.D. Vaginal irritation models: the current status of available alternative and in vitro tests. Altern. Lab. Anim. 2011, 39(4):317-337. (Sep).
11. D'Cruz O.J., Erbeck D., Uckun F.M. A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate. Toxicol. Pathol. 2005, 33(4):465-476.
12. Dalpke A.H., Heeg K. Synergistic and antagonistic interactions between LPS and superantigens. J. Endotoxin Res. 2003, 9(1):51-54.
13. da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 2001, 276:21129-21135.
14. Davis C.C., Kremer M.J., Schlievert P.M., Squier C.A. Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage. Am. J. Obstet. Gynecol. 2003, 189(6):1785-1791.
15. Davis J.P., Chesney P.J., Wand P.J., LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N. Eng. J. Med. 1980, 303(25):1429-1435.
16. Dimitrijevic D., Shaw A.J., Florence A.T. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells. J. Pharm. Pharmacol. 2000, 52(2):157-162. (Feb).
17. Dinges M.M., Orwin P.M., Schlievert P.M. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 2000, 13(1):16-34. (January, PMCID: PMC88931).
18. Fazeli A., Bruce C., Anuymba D.O. Characterization of Toll-like receptors in the female reproductive tract in humans. Hum. Reprod. 2005, 20:137-1378.
19. Garg S., Tambwekar K.R., Vermaini K., Garg A., Kaul C.L., Zanevvel L.J.D. Compendium of pharmaceutical excipients for vaginal formulations. Pharm. Technol. 2001, 25(Drug Delivery Suppl.):14-24. (North America).
20. Gali Y., Delezay O., Brouwers J., Addad N., Austijins P., Bourlet T., Hamzeh-Cognase H., Airen K.K., Pozzetto B., Vanham G. In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides. Antimicrob. Agents Chemother. 2010, 54(12):5105-5114.
21. Gouaux E. α-Hemolysin from Staphylococcus aureus: An archetype of β-barrel, channel-forming toxins. J. Struct. Biol. 1998, 121(2):110-122.
22. Grant W.M. Toxicology of the Eye: Effects on the Eyes and Visual System from Chemicals, Drugs, Metals and Mineral, Plants, Toxins and Venoms Also, Systemic Side Effects from Eye Medications 1986, 874. Charles C. Thomas, Springfield, IL. 3rd edition.
23. Hill D.R., Brunner M.E., Schmitz D.C., Davis C.C., Flood J.A., Schlievert P.M., Wang-Weigand S.Z., Osborn T.W. In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses. J. Appl. Physiol. 2005, 99(4):1582-1591.
24. Hill D.R., Davis C.C., Osborn T.W. Intravaginal and in vitro temperature changes with tampons of differing composition and absorbency. J. Biomed. Mater. Res. B Appl. Biomater. 2010, 92(2):535-541.
25. Kansal R., Davis C., Hansmann M., Seymour J., Parsonnet J., Modern P., Gilbert S., Kotb M. Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome. J. Clin. Immunol. 2007, 27(3):327-338.
26. Kass E.H., Kendrick M.I., Tsai Y.C., Parsonnet J. Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. J. Infect. Dis. 1987, 155(4):812-815.
27. Keane W.F., Gekker C., Schlievert P.M., Peterson P.K. Enhancement of endotoxin-induced renal tubular cell injury by toxic shock syndrome. Am. J. Pathol. 1986, 122(1):169-176.
28. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin. Microbiol. Rev. 1995, 8(3):411-426.
29. Linnemann C.C., Staneck J.L., Hornstein S., Barden T.P., Rauh J.L., Bonventre P.F., Buncher C.R., Beiting A. The epidemiology of genital colonization with Staphylococcus aureus. Ann. Intern. Med. 1982, 96(6 Pt 2):940-944.
30. Mak P. Hemocidins in a functional and structural context of human antimicrobial peptides. Front. Biosci. 2008, 13:6859-6871. (2008 May 1).
31. McNamara P.J., Syverson R.E., Milligan-Myhre K., Frolova O., Schroeder S., Kidder J., Hoang T., Proctor R.A. Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1. Antimicrob. Agents Chemother. 2009, 53(5):1898-1906.
32. Melish M.E., Fukunaga C., Murata S. Effect of Glycerol Monolaurate (GML) and Pluronic L92 (PL92) on Illness and TSST-1 Production in a Subcutaneous Depot Model for TSS. In European Conference on Toxic Shock Syndrome 1998, vol. 229:144. Royal Society of Medicine Services, London, UK, (Abstract). J.P. Arbuthnott, B. Furman (Eds.).
33. Moench T.R., Mumper R.J., Hoen T.E., Sun M., Cone R.A. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse. BMC Infect. Dis. 2010, 10:331. (http://www.biomedcentral.com/1471-2334/10/331).
34. Nicolazzo J.A., Reed B.L., Finnin B.C. The effect of various in-vitro conditions on the permeability characteristics of the buccal mucosa. J. Pharm. Sci. 2003, 92:2399-2410.
35. Nicolazzo J.A., Reed B.L., Finnin B.C. Assessment of the effects of sodium dodecyl sulfate on the buccal permeability of caffeine and estradiol. J. Pharm. Sci. 2004, 93(2):431-440.
36. Norris D. Immunological cytotoxicity of cutaneous targets. Immune Mechanisms in Cutaneous Disease 1989, 123-166. Marcel Dekker, New York. D.A. Norris (Ed.).
37. Parsonnet J., Hansmann M.A., Delaney M.L., Modern P.A., Dubois A.M., Wieland-Alter W., Wissemann K.W., Wild J.E., Jones M.B., Seymour J.L., Onderdonk A.B. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J. Clin. Microbiol. 2005, 43(9):4628-4634. 10.1128/JCM.43.9.4628-4634.2005.
38. Peterson M.L., Ault K., Kremer M.J., Klingelhutz A.J., Davis C.C., Squier C.A., Schlievert P.M. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect. Immun. 2005, 73(4):2164-2174.
39. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 1992, 9(5):663-669.
40. Raudrant D., Frappart L., De Hass P., Thoulon J.M., Charvet F. Study of the vaginal mucous membrane following tampon utilisation; aspect on colposcopy, scanning electron microscopy and transmission electron microscopy. Eur. J. Obstet. Gynecol. Reprod. Biol. 1989, 31(1):53-65.
41. Schlievert P.M., Blomster D.A. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J. Infect. Dis. 1983, 147(2):236-242.
42. Schlievert P.M., Bohach G.A. Staphylococcal and streptococcal superantigens: an update. Superantigens: Molecular Basis for Their Role in Human Diseases 2007, 21-36. ASM Press, Washington DC. M. Kotb, J.D. Fraser (Eds.).
43. Schlievert P.M., Case L.C., Nemeth K.A., Davis C.C., Sun Y., Qin W., Wang F., Brosnahan A.J., Mleziva J.A., Peterson M.L., Jones B.E. Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins. Biochemistry 2007, 46(50):14349-14358. 10.1021/bi701202w.
44. Schlievert P.M., Nemeth K.A., Davis C.C., Peterson M.L., Jones B.E. Staphylococcus aureus exotoxins are present in vivo in tampons. Clin. Vac. Immunol. 2010, 17(5):722-727.
45. Schlievert P.M., Shands K.N., Dan B.B., Schmid G.P., Nishimura R.D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 1981, 143(4):509-516.
46. Serfaty D., Cohen J. The contraceptive benzalkonium chloride tampon. Contracept. Fertil. Sex. 1984, 12(4):569-572.
47. Shands K.N., Schmid G.P., Dan B.B., Blum D., Guidotti R.J., Hargrett N.T., Anderson R.L., Hill D.L., Broome C.V., Band J.D., Fraser D.W. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 1980, 303(25):1436-1442.
48. Shupp J.W., Jett M., Pontzer C. Identification of a transcytosis epitope on staphylococcal enterotoxins. Infect. Immun. 2002, 70(4):2178-2186.
49. Squier C.A., Hall B.K. In vitro permeability of porcine oral mucosa after epithelial separation, stripping and hydration. Arch. Oral Biol. 1985, 30:485-491.
50. Squier C.A., Mantz M.J., Schlievert P.M., Davis C.C. Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J. Pharm. Sci. 2008, 97(1):9-21.
51. U.S.Food and Drug Administration Data through September. Inactive Ingredient Search for Approved Drug Products 2013, FDA, Washington, DC, (http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm).
52. van der Bijl P., de Blois A.M., van Eyk A.D., Thompson I.O. Permeability of vaginal mucosa to water at normal and elevated temperatures. S. Afr. Dent. 2000, 55(4):206-210.
53. van der Bijl P., van Eyk A.D. Human vaginal mucosa as a model of buccal mucosa for in-vitro permeability studies: an overview. Curr. Drug Deliv. 2004, 1:129-135.
54. van Eyk A.D., van der Bijl P. The culture of human buccal and vaginal epithelial cells for permeability studies. SADJ 1998, 53:497-503.
55. Wagner G., Ottesen B. Vaginal physiology during menstruation. Ann. Intern. Med. 1982, 96(6 Pt 2):921-923.
56. Wertz P.W., Squier C.A. Biochemical basis of the permeability barrier in skin and oral mucosa. Oral Mucosal Drug Delivery 1996, Marcel Dekker Inc., New York. M.J. Rathbone, J. Hadgraft (Eds.).
57. Wertz P.W., van den Berg B. The physical, chemical, and function properties of lipids in the skin and other biological barriers. Chem. Phys. Lipids 1998, 91:85-96.
58. Westphal O., Jann K. Bacterial lipopolysaccharide-extraction with phenol-water and further application of procedure. Met. Carbohydr. Chem. 1965, 5:83-91.
59. Yu L., Wang L., Chen S. Toll-Like receptors, inflammation and tumor in the human reproductive tract. Am. J. Reprod. Immunol. 2009, 62:1-8.